Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US based specialized pharma product company Antares Pharma has appointed Paul Wotton as its new president and COO.
Subscribe to our email newsletter
Previously, Dr Wotton served as CEO of Topigen Pharmaceuticals. Prior to joining Topigen, Dr Wotton served as head of global business development at SkyePharma.
Dr Wotton has over 20 years experience in the pharmaceutical industry with both large and specialty pharma companies. He received his PhD in pharmaceutical science from the University of Nottingham.
Jack Stover, CEO of Antares Pharma, said: “We are pleased to have Dr Wotton, a seasoned executive, join Antares; he brings a wealth of business and product development experience to our executive management team.”